Sudarshan Pharma FCCB Conversion Meeting on August 19

Event Disclosure

The company has scheduled a meeting of its FCCB Committee to be held on Wednesday, 19th August 2026.

The primary agenda of the meeting is to consider and approve:

• Conversion of a portion of funds raised through Foreign Currency Convertible Bonds (FCCB) issue into equity shares
• Allotment of the converted equity shares